Charles L. Pope
Known title: DirectorCIK: 0001136354
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
SCNX Shares Drop 19% After Hours Amid Reverse Split. SCNX shares fell 19% in after‑hours trading after the company announced a reverse stock split. The reverse split will consolidate shares, potentially raising the share price but also reducing the number of shares outstanding. The drop comes while the stock sits near its 12‑month low and has a very low RSI, indicating a possible oversold condition. The reverse split may be a move to meet listing requirements and support future trading.
Transaction History
| OGEN | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 | View on chart |
| SCNX | ▲ Buy | Grant | 54,525 | $0 | 9/1/2022 | View on chart |
| SCNX | ▲ Buy | Grant | 10,912 | $41K | 5/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Oragenics (OGEN) noted in after‑market health‑care stock activity
OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.
Oragenics (OGEN) noted in after‑market health‑care stock activity. OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.